Anaptysbio Inc (ANAB)
$15.88
0.28 (1.73%)
ANAB Stock Quote Delayed 15 Minutes
Previous Close
$15.88
Market Cap
373.14M
PE Ratio
-11.34
EPS
-1.4
Volume (Avg. Vol.)
574,500
Day's Range
15.55 - 16.34
52-Week Range
10.00 - 83.10
Dividend & Yield
N/A (N/A)
ANAB Stock Predictions, Articles, and Anaptysbio Inc News
AnaptysBio Earnings: Why ANAB Stock Is Plunging 72%
AnaptysBio (ANAB) earnings for the antibody development company's third quarter of 2019 have ANAB stock taking a dive on Friday.
Tread Very Carefully When Investing in AnaptysBio Inc
ANAB is up on positive clinical studies posted in the last few months. But the small sample size and risks ahead could hurt the stock in the near term.
3 Stocks to Watch on Tuesday: Aimmune Therapeutics Inc (AIMT), AnaptysBio Inc (ANAB) and SM Energy Co (SM)
Aimmune Therapeutics (AIMT), AnaptysBio (ANAB) and SM Energy (SM) all made headlines, with the first two developing peanut allergy medications with encouraging results.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
